Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer's disease.

MLA

Kivisäkk, Pia, et al. “Clinical Evaluation of a Novel Plasma PTau217 Electrochemiluminescence Immunoassay in Alzheimer’s Disease.” Scientific Reports, vol. 14, no. 1, Jan. 2024, p. 629. EBSCOhost, https://doi.org/10.1038/s41598-024-51334-x.

APA

Kivisäkk, P., Fatima, H. A., Cahoon, D. S., Otieno, B., Chacko, L., Minooei, F., Demos, C., Stengelin, M., Sigal, G., Wohlstadter, J., & Arnold, S. E. (2024). Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer’s disease. Scientific Reports, 14(1), 629. https://doi.org/10.1038/s41598-024-51334-x

Chicago

Kivisäkk, Pia, Hadia A Fatima, Danielle S Cahoon, Brunah Otieno, Leena Chacko, Farnaz Minooei, Catherine Demos, et al. 2024. “Clinical Evaluation of a Novel Plasma PTau217 Electrochemiluminescence Immunoassay in Alzheimer’s Disease.” Scientific Reports 14 (1): 629. doi:10.1038/s41598-024-51334-x.